- Startup company Bonac Corp. to start human clinical trial for a COVID-19 drug in 2021.
- The startup company is based in Kurume, Fukuoka Prefecture.
- The company has currently developed 72 possible COVID-19 drug candidates for the trials.
- The company will be using RNA inference technology in its drug.
According to a report, a biotechnology st....
Tags : JAPAN, FUKUOKA PREFECTURE, BIOTECHNOLOGY STARTUP BONAC CORP., HUMAN CLINIAL TRIAL, COVID-19 DRUG, RNA INTERFERENCE TECHNOLOGY DRUG, FUKUOKA INSTITUTE OF HEALTH AND ENVIRONMENTAL SCIENCES,